The Key to Healthcare Campaign Success: Work Backwards
No vaccines were yet approved. The world was searching for answers. It was at this time (July 2020) that Johns Hopkins School of Medicine received $35MM in funding from the U.S. Department of Defense (DOD) for two nationwide clinical trials to test the effectiveness of a convalescent blood plasma outpatient treatment. The goal was to see if this treatment could prevent and/or decrease hospitalizations and deaths associated with Covid-19.
